According to SEC filings for the period ending September 2025, Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) is held by 126 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 30 Sep, 2025 | 7,692,298 | 0 | 0.00% | $56,999,928.00 |
| BVF INC/IL | 30 Sep, 2025 | 5,660,132 | 0 | 0.00% | $41,941,578.00 |
| Versant Venture Management, LLC | 30 Sep, 2025 | 5,652,922 | 0 | 0.00% | $41,888,152.00 |
| BAKER BROS. ADVISORS LP | 30 Sep, 2025 | 4,916,095 | 0 | 0.00% | $36,428,264.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 4,637,060 | -1,688,598 | -26.69% | $34,362.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,815,133 | -31,321 | -0.81% | $28,270,135.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 3,360,000 | 0 | 0.00% | $24,897,600.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,988,953 | -151,557 | -4.83% | $22,148,142.00 |
| FMR LLC | 30 Sep, 2025 | 2,812,251 | 524,217 | 22.91% | $20,838,780.00 |
| Aisling Capital Management LP | 30 Sep, 2025 | 1,472,331 | 0 | 0.00% | $10,909,973.00 |
| Alphabet Inc. | 30 Sep, 2025 | 1,464,015 | 0 | 0.00% | $10,848,351.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,151,566 | 27,406 | 2.44% | $8,534,702.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 902,834 | 456,754 | 102.39% | $6,690,001.00 |
| STATE STREET CORP | 30 Sep, 2025 | 846,773 | 14,954 | 1.80% | $6,274,588.00 |
| Vestal Point Capital, LP | 30 Sep, 2025 | 800,000 | 375,000 | 88.24% | $5,928,000.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 740,684 | -20,735 | -2.72% | $5,488,469.00 |
| AQR CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 717,262 | -566,680 | -44.14% | $5,314,912.00 |
| Parkwood LLC | 30 Sep, 2025 | 708,000 | 0 | 0.00% | $5,246.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 694,942 | 663,786 | 2,130.52% | $5,149,520.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 645,196 | 74,746 | 13.10% | $4,780,904.00 |